| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the * Miami Project to Cure Paralysis and the
Department of Urology, University of Miami
School of Medicine, Miami, Florida.
| Correspondence to: Dr Nancy L Brackett, The Miami Project to Cure Paralysis, University of Miami School of Medicine, PO Box 016960, R-48, Miami, FL 33101 (e-mail: NBrackett{at}miami.edu). |
| Received for publication July 9, 2003; accepted for publication September 30, 2003. |
| Abstract |
|---|
|
|
|---|
, TNFß,
INF
, respectively) and Th2 effector functions: interleukin 4,
interleukin 6, interleukin 10, transforming growth factor beta 1 (IL4, IL6,
IL10, TGFß1, respectively). The results showed a predominance of Th1
versus Th2 cytokine production in the seminal plasma of men with SCI compared
with that of control subjects. This finding suggests an immunologic basis for
infertility as a possible avenue of investigation in these men.
Key words: Sperm, infertility, semen, T cells, Th1, Th2
is a key cytokine
associated with Th1 differentiation and a cell-mediated immune response, while
IL4 and IL5 are associated with Th2 differentiation and a humoral or
antigen-mediated immune response (ie, stimulating and augmenting B-cell
activity) (Abbas et al,
2000). | Materials and Methods |
|---|
|
|
|---|
Semen Analysis![]()
A semen analysis was performed on each fresh semen specimen using World
Health Organization (World Health
Organization, 1999) criteria. All semen analyses were performed by
the same technician.
Semen Collection![]()
In SCI subjects, antegrade semen specimens were collected by the standard
method of penile vibratory stimulation
(Brackett, 1999). Retrograde
ejaculates and electroejaculates were not used in this study because these
procedures have been shown to alter semen quality
(Brackett and Lynne, 2000).
When possible, up to 3 semen specimens were collected from each SCI subject to
achieve a final volume of
2 mL semen per subject, which was the minimum
volume necessary to perform all cytokine assays. Multiple semen collections
from the same SCI subject occurred at 2- to 4-week intervals, with no
additional ejaculations between semen collections. Each semen specimen was
centrifuged at 400 x g for 10 minutes at room temperature to
obtain the seminal plasma fraction. The protease inhibitor, phenyl methyl
sulphonyl fluoride (PMSF), was added to the seminal plasma to a final
concentration of 0.5 mM (Gruschwitz et al,
1996). The PMSF-treated seminal plasma fractions were then stored
in 1.5 mL microfuge tubes at 80°C until use. Control subjects
collected their semen specimens by masturbation following 3 to 7 days of
abstinence from ejaculation. Semen specimens from control subjects were
processed in the same manner as semen specimens from SCI subjects.
Cytokine Determination in Seminal Plasma![]()
The following 10 cytokines were measured in the seminal plasma of SCI and
control subjects: IL1ß, IL2, IL12, TNF
, TNFß, INF
,
IL4, IL6, IL10, TGFß1. Because the volume of ejaculate available from
each subject was limited, in some instances multiple ejaculates from the same
subject were collected and pooled. Even so, since duplicate determinations of
each assay were performed, it was not possible to assay all 10 cytokines in
each subject. Frozen seminal plasma was thawed at room temperature immediately
prior to cytokine determination. Quantitation of these cytokines was done
using ELISA kits (R&D Systems, Minneapolis, Minn). Briefly, a solid phase
enzyme immunoassay employing the multiple antibody sandwich principle was
applied. The microtiter plate was coated with antihuman monoclonal antibody
specific for the cytokines. The immobilized antibody binds any cytokine
present in the seminal plasma. A goat polyclonal antibody was added to which
streptavidine-peroxidase was bound to biotin. The chromogen used was
tetramethyl benzidine, the reaction stopped by using 2N
H2SO4. Optical density readings were performed at 450 nm
and corrected at 540 nm using a Wallac ELISA
reader.
|
Cytokine Determination in Blood Serum![]()
As a follow-up experiment to finding elevated semen cytokine concentrations
in SCI subjects, cytokine concentrations were measured in the blood serum of
SCI subjects to determine if the elevations were a local or systemic effect.
Blood serum was not collected from control subjects since elevated semen
cytokine concentrations were not observed in control subjects.
One serum specimen was collected from each of 12 randomly selected SCI
subjects. Blood was collected by venipuncture into vacutainer tubes, allowed
to clot for 15 minutes, then centrifuged at 400 x g for 15
minutes to obtain serum. Serum specimens were treated similarly to seminal
plasma, that is, serum was treated with PMSF, then frozen at 80°C
until use. The presence of cytokines IL1ß, IL6, and TNF
was
determined using ELISA as described above for cytokine determination in the
seminal plasma.
Statistical Analysis![]()
Group means were compared by analysis of variance. Fisher exact test was
used in one instance to assess the significance of the finding that control
subjects contained no IFN
in their seminal plasma versus SCI subjects
who contained a broad range of this cytokine (0141.13 pg/mL) in their
seminal plasma.
| Results |
|---|
|
|
|---|
Cytokine Determination in the Seminal Plasma![]()
Of the cytokines typically elaborated by the Th1 subset of helper T cells,
concentrations of IL1ß, IL12, and TNF
were significantly elevated
in the seminal plasma of SCI subjects compared with control subjects
(Figure 1). IL2 and TNFß
were not present in the seminal plasma of SCI or control subjects. Likewise,
IFN
was not present in the seminal plasma of any control subject but
was present in the seminal plasma of two thirds of the SCI subjects. Although
the difference in mean concentrations of IFN
in SCI versus control
subjects did not reach statistical significance (probably due to the wide
range of IFN
concentrations in the SCI group: 0.0141.13 pg/mL),
the occurrence of this finding was significant when analyzed by the Fisher
exact test (P < .05).
|
Of the cytokines typically elaborated by the Th2 subset of helper T cells, only IL6 was significantly elevated in the seminal plasma of SCI subjects compared with control subjects (Figure 2). There was no difference between SCI and control subjects in the concentrations of IL10. Concentrations of IL4 and TGFß1 were significantly decreased in the seminal plasma of SCI versus control subjects.
|
Cytokine Concentrations in Blood Sera![]()
IL1ß, IL6, and TNF
were not detected in the serum of men with
SCI (data not shown).
| Discussion |
|---|
|
|
|---|
were significantly higher, whereas
concentrations of IL4 and TGFß1 were significantly lower in the seminal
plasma of men with SCI compared with healthy non-SCI men. The presence of
IFN
in the seminal plasma of SCI men where none was found in controls
was likewise significant. Proinflammatory cytokines have been detected in the
semen of men with inflammation-related infertility
(Shimoya et al, 1993;
Naz and Kaplan, 1994;
Rajasekaran et al, 1995;
Huleihel et al, 1996); however, these studies have been conducted only in infertile non-SCI men. Our
study examined the SCI male population. As with previous studies, semen
parameters were found to be abnormal in the SCI group. No detectable levels of
IL1ß, IL6, or TNF
were found in the blood sera of SCI subjects,
suggesting that the observed inflammatory response was restricted to the
urogenital tract. Cytokines rarely act in isolation, but rather in a network of other cytokines, many of which may be inhibitory or immunoregulatory. Two such cytokines, IL4 and TGFß1 were found to be lower in the seminal plasma of SCI men. TGFß is a cytokine with autocrine and paracrine actions in the testis with potent immunoregulatory and anti-inflammatory activity (Loras et al, 1999). IL4 inhibits the production of a wide range of cytokines from stimulated monocytes (Mire-Sluis and Thorpe, 1998). One study (Naz and Evans, 1998) noted that IL12 was higher in fertile versus infertile men and was correlated with sperm count, but not sperm motility. Our study, however, showed increased concentrations of IL12 in seminal plasma of men with SCI (12.5 pg/mL) compared with those of controls (5.0 pg/mL).
Studies by Estrada et al
(1997) and Paradisi et al
(1996) showed that IFN
had a somewhat detrimental effect on sperm motility and viability. In our
study, IFN
was present in the seminal plasma of 8 of the 12 SCI men
tested for this cytokine and in none of the control subjects tested
(P < .05).
The concentrations of IL1ß, IL6, and TNF
were greatly elevated
in seminal plasma of men with SCI. Presence of IL1 in human seminal plasma and
its influence in membrane peroxidation and fertility has been reported
(Buch et al, 1994). Various
studies have shown that IL1 in very high concentrations can have an adverse
affect on sperm motility and fertilization
(Naz, 1985;
Anderson and Hill, 1988).
However, the direct influence of cytokines such as IL1ß and TNFß is
a topic of controversy (Hill et al,
1987; Haney et al,
1992). Studies have also shown an inverse correlation between
sperm number and motion parameters and seminal IL6 levels
(Naz and Kaplan, 1994). IL6 is
a pleiotrophic cytokine produced by different types of cells. According to
Matalliotakis et al, the prostate appears to be the main site for origin of
IL6 in the semen (Matalliotakis et al,
1998b).
In vitro studies have shown that recombinant TNF
does not affect
human sperm motility (Wincek et al,
1991). The effects of TNF
on sperm motility, sperm
penetration, and mouse embryo development was shown by Hill et al
(1987). The cytotoxic effects
of TNF
are normally mediated through membrane receptor mechanisms
linked to protein synthesis. Many effects are mediated by activation of the
TNF
receptor pathways, including nuclear factor kappa B (NF
B)
activation and induction of apoptotic processes. Our data showed that
TNF
was not found in detectable levels in control subjects. Even though
its correlation with sperm motility and viability could not be determined due
to absence of TNF
in control subjects, its presence in the seminal
plasma of SCI subjects suggests a possible role in infertility.
Another mechanism of interference with sperm quality may be an adverse effect on sperm membrane properties such as lipid peroxidation (Buch et al, 1994). Increased oxidative stress may additionally modulate the concentration of these cytokines (Rajasekaran et al, 1995). Reactive oxygen species (ROS) might also play a role in reducing sperm motility along with cytotoxic cytokines. It has been shown that semen samples of SCI patients showed high levels of ROS, which was inversely related to sperm motility and positively related to polymorphonuclear neutrophils (Padron et al, 1997).
The role of abnormal sperm storage in the seminal vesicles of SCI men (Ohl et al, 1999) in contributing to the abnormal levels of cytokines, WBC, and overall sperm quality is unclear. It is tempting to assign all the abnormalities to this possibility. However, repeated frequent ejaculations (which should minimize the effects of abnormal storage) do not seem to change semen quality in these men (Sonksen et al, 1999).
Whereas cells of the immune system are the major sources of these cytokines, other cells in the reproductive tract might be capable of cytokine expression. It has been suggested that the prostate gland is the site of origin of IL6 (Matalliotakis et al, 1998b). Studies have suggested that there are both endogenous and exogenous factors that might affect sperm motility (Majumder et al, 1990; de Lamirande and Gagnon, 1993). The precise origin of the cytokines, however, remains unclear. Presumably they are produced by WBC present in abnormally high numbers in the semen of men with SCI (Basu et al, 2002; Trabulsi et al, 2002). The origin of these WBC is unclear and may not be related to chronic infection or inflammation. For example, many men post retroperitoneal lymph node dissection (RPLND) share the same abnormal sperm profiles and ejaculatory dysfunction with men who have SCI but not the stigmata of bladder dysfunction, UTI, and so forth. Their commonality with SCI men is autonomic disinnervation of the accessory sex glands, a condition whose role is unclear with respect to immune function and regulation. Treatment of UTIs does not seem to make a major difference in the sperm parameters of men with SCI (Ohl et al, 1992). A biopsy study of the prostate glands of SCI versus control subjects showed no evidence of any significant acute or chronic inflammatory changes in the prostate glands of SCI men (Randall et al, 2003).
A previous study by our group showed that seminal plasma from men with SCI rapidly and profoundly reduced sperm motility of normal men (Brackett et al, 1996a). Additionally, sperm obtained from the vas deferens of men with SCI had significantly higher motility than that of their ejaculates (Brackett et al, 2000). Taken together, these studies indicate that when sperm of men with SCI comes into direct contact with their seminal plasma, sperm motility decreases. Further experiments will be required to prove the exact involvement of cytokines in reducing sperm motility. However, identification of the exact cyokines involved in this response will lead to the development of strategies to neutralize, eliminate, or otherwise combat these substances and their noxious effects.
| Conclusion |
|---|
|
|
|---|
, and TNF
, and lower concentrations of IL4 and
TGFß1 in the seminal plasma of men with SCI compared with non-SCI healthy
control subjects. Many of the cytokines were either not detectable or not
present in the seminal plasma of control subjects. This finding suggests a
cell mediated versus a humoral immunologic basis for infertility as a possible
avenue of investigation in these men. | Footnotes |
|---|
| References |
|---|
|
|
|---|
Anderson DJ, Hill JA. Cell-mediated immunity in infertility. Am J Rep Immunol.1988;17: 22 30.
Basu S, Lynne CM, Ruiz P, Aballa TC, Ferrell SM, Brackett NL.
Cytofluorographic identification of activated T-cell populations in the semen
of men with spinal cord injuries. J Androl. 2002; 23: 551
556.
Brackett NL. Semen retrieval by penile vibratory stimulation in men
with spinal cord injury. Hum Reprod Update. 1999; 5: 216
222.
Brackett NL, Davi RC, Padron OF, Lynne CM. Seminal plasma of spinal cord injured men inhibits sperm motility of normal men. J Urol. 1996a;155: 1632 1635.[Medline]
Brackett NL, Ferrell SM, Aballa TC, et al. An analysis of 653 trials of penile vibratory stimulation on men with spinal cord injury. J Urol. 1998;159: 1931 1934.[Medline]
Brackett NL, Lynne CM. The method of assisted ejaculation affects the outcome of semen quality studies in men with spinal cord injury: a review. Neurorehab. 2000; 15: 89 100.
Brackett NL, Lynne CM, Aballa TC, Ferrell SM. Sperm motility from the vas deferens of spinal cord injured men is higher than from the ejaculate. J Urol. 2000;164: 712 715.[Medline]
Brackett NL, Nash MS, Lynne CM. Male fertility following spinal
cord injury: facts and fiction. Phys Ther. 1996b; 76: 1221
1231.
Buch JP, Kolon TF, Maulik N, Kreutzer DL, Das DK. Cytokines stimulate lipid membrane peroxidation of human sperm. Fertil Steril. 1994;62: 186 188.[Medline]
de Lamirande E, Gagnon C. A positive role for the superoxide anion in triggering hyperactivation and capacitation of human spermatozoa. Int J Androl. 1993; 16: 21 25.[Medline]
Dousset B, Hussenet F, Daudin M, Bujan L, Foliguet B, Nabet P.
Seminal cytokine concentrations (IL-1beta, IL-2, IL-6, sR IL-2, sR IL-6),
semen parameters and blood hormonal status in male infertility. Hum
Reprod. 1997;12: 1476
1479.
Estrada LS, Champion HC, Wang R, et al. Effect of tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human sperm motility, viability and motion parameters. Int J Androl. 1997;20: 237 242.[Medline]
Gruschwitz MS, Brezinschek R, Brezinschek HP. Cytokine levels in
the seminal plasma of infertile males. J Androl. 1996; 17: 158
163.
Haney AF, Hughes SF, Weinberg JB. The lack of effect of tumor
necrosis factor-alpha, interleukin-1-alpha, and interferon-gamma on human
sperm motility in vitro. J Androl. 1992; 13: 249
253.
Hill JA, Haimovici F, Politch JA, Anderson DJ. Effects of soluble products of activated lymphocytes and macrophages (lymphokines and monokines) on human sperm motion parameters. Fertil Steril. 1987; 47: 460 465.[Medline]
Huleihel M, Lunenfeld E, Levy A, Potashnik G, Glezerman M. Distinct expression levels of cytokines and soluble cytokine receptors in seminal plasma of fertile and infertile men. Ferti Steril. 1996; 66: 135 139.[Medline]
Klose KJ, Green BA, Smith RS, Adkins RH, MacDonald AM. University of Miami Neuro-Spinal Index (UMNI): a quantitative method for determining spinal cord function. Paraplegia. 1980; 18: 331 334.[Medline]
Linsenmeyer TA. Male infertility following spinal cord injury. J Am Paraplegic Soc. 1991; 14: 116 121.[Medline]
Loras B, Vetele F, El Malki A, Rollet J, Soufir JC, Benahmed M.
Seminal transforming growth factor-beta in normal and infertile men.
Hum
Reprod.1999;14: 1534
1539.
Majumder GC, Dey CS, Haldar S, Barua M. Biochemical parameters of initiation and regulation of sperm motility. Arch Androl. 1990;24: 287 303.[Medline]
Matalliotakis I, Kiriakou D, Fragouli I, Sifakis S, Eliopoulos G, Koumantakis E. Interleukin-6 in seminal plasma of fertile and infertile men. Arch Androl. 1998a; 41: 43 50.[Medline]
Matalliotakis I, Sifakis S, Goumemou A, et al. Cytokine levels in seminal plasma. Clin Exp Obst Gyn. 1998b; 25: 58 60.
Mire-Sluis AR, Thorpe R. Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. J Immunol Meth. 1998;211: 199 210.[Medline]
Naz RK: Role of cell mediated immunity in infertility. In: Naz RK, ed. Immunology of Reproduction. Boca Raton, Fla: CRC Press; 1985: 6180.
Naz RK, Evans W. Decreased levels of interleukin-12 are not correlated with leukocyte concentration and superoxide dismutase activity in semen of infertile men. Arch Androl. 1998; 41: 91 96.[Medline]
Naz RK, Kaplan P. Increased levels of interleukin-6 in seminal
plasma of infertile men. J Androl. 1994; 15: 220
227.
Ohl DA, Denil J, Fitzgerald-Shelton K, et al. Fertility of spinal cord injured males: effect of genitourinary infection and bladder management on results of electroejaculation. J Am Paraplegic Soc. 1992; 15: 53 59.[Medline]
Ohl DA, Menge A, Jarow J. Seminal vesicle aspiration in spinal cord injured men: insight into poor semen quality. J Urol. 1999; 162: 2048 2051.[Medline]
Padron OF, Brackett NL, Sharma RK, Lynne CM, Thomas AJ Jr, Agarwal A. Seminal reactive oxygen species and sperm motility and morphology in men with spinal cord injury. Fertil Steril. 1997; 67: 1115 1120.[Medline]
Paradisi R, Capelli M, Mandini M, Bellavia E, Flamigni C. Increased levels of interferon-gamma in seminal plasma of infertile men. Andrologia. 1996; 28: 157 161.[Medline]
Rajasekaran M, Hellstrom WJ, Naz RK, Sikka SC. Oxidative stress and interleukins in seminal plasma during leukocytospermia. Fertil Steril. 1995;64: 166 171.[Medline]
Randall JM, Evans DH, Bird VG, Aballa TC, Lynne CM, Brackett NL. Leukocytospermia in spinal cord injured patients is not related to histological inflammatory changes in the prostate. J Urol. 2003;170: 897 900.[Medline]
Shimoya K, Matsuzaki N, Tsutsui T, Taniguchi T, Saji F, Tanizawa O. Detection of interleukin-8 (IL-8) in seminal plasma and elevated IL-8 in seminal plasma of infertile patients with leukospermia. Fertil Steril. 1993;59: 885 888.[Medline]
Sonksen J, Biering-Sorensen F. Fertility in men with spinal cord or cauda equina lesions. Semin Neurol. 1992; 12: 106 114.[Medline]
Sonksen J, Ohl DA, Giwercman A, Biering-Sorensen F, Skakkebaek NE, Kristensen JK. Effect of repeated ejaculation on semen quality in spinal cord injured men. J Urol. 1999; 161: 1163 1165.[Medline]
Trabulsi EJ, Shupp-Byrne D, Sedor J, Hirsh IH. Leukocyte subtypes in electroejaculates of spinal cord injured men. Arch Phys Med Rehabil. 2002;83: 31 33.[Medline]
Wincek TJ, Meyer TK, Meyer MR, Kuehl TJ. Absence of a direct effect of recombinant tumor necrosis factor-alpha on human sperm function and murine preimplantation development.[comment]. Fertil Steril. 1991; 56: 332 339.[Medline]
World Health Organization. Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucous Interaction. Cambridge, United Kingdom: Cambridge University Press; 1999 .
This article has been cited by other articles:
![]() |
N. L. Brackett, E. Ibrahim, J. A. Grotas, T. C. Aballa, and C. M. Lynne Higher Sperm DNA Damage in Semen From Men With Spinal Cord Injuries Compared With Controls J Androl, January 1, 2008; 29(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Brannigan Editorial Commentary J Androl, January 1, 2008; 29(1): 100 - 101. [Full Text] [PDF] |
||||
![]() |
N. L. Brackett, D. R. Cohen, E. Ibrahim, T. C. Aballa, and C. M. Lynne Neutralization of Cytokine Activity at the Receptor Level Improves Sperm Motility in Men With Spinal Cord Injuries J Androl, September 1, 2007; 28(5): 717 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Purdue, L. C. Sakoda, B. I. Graubard, R. Welch, S. J. Chanock, I. A. Sesterhenn, M. V. Rubertone, R. L. Erickson, and K. A. McGlynn A Case-Control Investigation of Immune Function Gene Polymorphisms and Risk of Testicular Germ Cell Tumors Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhu, N. L. Brackett, T. C. Aballa, C. M. Lynne, M. A. Witt, H. I. Kort, and W. E. Roudebush High Seminal Platelet-Activating Factor Acetylhydrolase Activity in Men With Spinal Cord Injury J Androl, May 1, 2006; 27(3): 429 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gopichandran, U. V Ekbote, J. J Walker, D. Brooke, and N. M Orsi Multiplex determination of murine seminal fluid cytokine profiles. Reproduction, March 1, 2006; 131(3): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Cohen, S. Basu, J. M. Randall, T. C. Aballa, C. M. Lynne, and N. L. Brackett Sperm Motility in Men With Spinal Cord Injuries Is Enhanced by Inactivating Cytokines in the Seminal Plasma J Androl, November 1, 2004; 25(6): 922 - 925. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |